ARCHIVES

Avon Awards $50 Million To NCI And Three Centers.

This article is from The Cancer Letter archive.

Vol. 27 No. 37 | October 12, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977